As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that ...

As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the ...

As researchers work to improve treatment of Alzheimer’s disease ... form of a protein in the brain caused by the disease and improved memory in mice by boosting production of a protective ...

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis. The test, dubbed the Lumipulse G pTau217/ß ...

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

What’s the difference between Alzheimer’s and dementia? Alzheimer’s disease is a disorder of the brain that negatively affects memory, thinking, and reasoning, while dementia is an umbrella ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease. The FDA has cleared the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio ...

The prognosis for Alzheimer’s disease is much better when patients are diagnosed as early as possible. And there’s great news on that front. WTOP talked to two local doctors about an ...

Past studies show that certain lifestyle factors, such as exercising regularly, may help lower a person’s risk for Alzheimer’s disease. A new study says that older adults who spend more time ...

2025 — Learning about one's risk for Alzheimer's disease may not lead to emotional distress, but motivation to maintain healthy lifestyle changes tends to ... May 6, 2025 — A new study ...